View in EDS PDF Full Text

Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.

Saved in:
Bibliographic Details
Title: Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.
Authors: McGuirk M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Khan MA; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Bellman P; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Mudaranthakam DP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Lutfi F; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Bansal R; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Abdelhakim H; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Gorsline C; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Shoemaker DM; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Abhyankar SH; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America., Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America. Electronic address: mmushtaq@kumc.edu.
Source: Transplant immunology [Transpl Immunol] 2024 Jun; Vol. 84, pp. 102039. Date of Electronic Publication: 2024 Mar 19.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5492 (Electronic) Linking ISSN: 09663274 NLM ISO Abbreviation: Transpl Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38513813
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McGuirk+M%22">McGuirk M</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Shahzad+M%22">Shahzad M</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Amin+MK%22">Amin MK</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Khan+MA%22">Khan MA</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Bellman+P%22">Bellman P</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Mudaranthakam+DP%22">Mudaranthakam DP</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22DeJarnette+S%22">DeJarnette S</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Lutfi+F%22">Lutfi F</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Ahmed+N%22">Ahmed N</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Bansal+R%22">Bansal R</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Abdelhakim+H%22">Abdelhakim H</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Gorsline+C%22">Gorsline C</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Shoemaker+DM%22">Shoemaker DM</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Abdallah+AO%22">Abdallah AO</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Shune+L%22">Shune L</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Abhyankar+SH%22">Abhyankar SH</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Singh+AK%22">Singh AK</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22McGuirk+JP%22">McGuirk JP</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.<br /><searchLink fieldCode="AU" term="%22Mushtaq+MU%22">Mushtaq MU</searchLink>; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America. Electronic address: mmushtaq@kumc.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229309923%22">Transplant immunology</searchLink> [Transpl Immunol] 2024 Jun; Vol. 84, pp. 102039. <i>Date of Electronic Publication: </i>2024 Mar 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9309923 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-5492 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209663274%22">09663274 </searchLink><i>NLM ISO Abbreviation: </i>Transpl Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38513813
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.trim.2024.102039
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102039
    Titles:
      – TitleFull: Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McGuirk M
      – PersonEntity:
          Name:
            NameFull: Shahzad M
      – PersonEntity:
          Name:
            NameFull: Amin MK
      – PersonEntity:
          Name:
            NameFull: Khan MA
      – PersonEntity:
          Name:
            NameFull: Bellman P
      – PersonEntity:
          Name:
            NameFull: Mudaranthakam DP
      – PersonEntity:
          Name:
            NameFull: DeJarnette S
      – PersonEntity:
          Name:
            NameFull: Lutfi F
      – PersonEntity:
          Name:
            NameFull: Ahmed N
      – PersonEntity:
          Name:
            NameFull: Bansal R
      – PersonEntity:
          Name:
            NameFull: Abdelhakim H
      – PersonEntity:
          Name:
            NameFull: Gorsline C
      – PersonEntity:
          Name:
            NameFull: Shoemaker DM
      – PersonEntity:
          Name:
            NameFull: Abdallah AO
      – PersonEntity:
          Name:
            NameFull: Shune L
      – PersonEntity:
          Name:
            NameFull: Abhyankar SH
      – PersonEntity:
          Name:
            NameFull: Singh AK
      – PersonEntity:
          Name:
            NameFull: McGuirk JP
      – PersonEntity:
          Name:
            NameFull: Mushtaq MU
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2024 Jun
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1878-5492
          Numbering:
            – Type: volume
              Value: 84
          Titles:
            – TitleFull: Transplant immunology
              Type: main
ResultId 1